Nick Devita

Nick DeVita currently holds a position at Merck as part of the Rare Disease - RDAS team in the Central Region, starting in July 2023. Prior to this role, Nick worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as a team member in Rare Disease for the Mid-Atlantic region from June 2022 to July 2023. Nick's extensive experience includes a tenure at Pfizer from 2006 to June 2022 in Sales Business Development. Additionally, Nick has served in various advisory and leadership capacities, including as an Advisor and Board member at both Intrensic and SaferMobility, co-founding and managing Powhatan Group, and participating on the Board of the Emerging Leaders Council at the Science Museum of Virginia. Nick also contributed as a Board Member for the Massey Alliance at Virginia Commonwealth University. Nick holds a Master's degree in Business Administration and Management from The Johns Hopkins University and has attended the University of Richmond's Robins School of Business.